IOL Chemicals & Pharmaceuticals
add_icon

IOL Chemicals & Pharmaceuticals

89.11
-3.47
(-3.75%)
Market Cap
2,615.62 Cr
PE Ratio
23.45
Volume
14,65,717.00
Day High - Low
93.60 - 87.50
52W High-Low
126.66 - 60.90
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
2,615.62 Cr
EPS
3.44
PE Ratio
23.45
PB Ratio
1.55
Book Value
59.66
EBITDA
224.70
Dividend Yield
0.86 %
Industry
Healthcare
Return on Equity
5.99
Debt to Equity
0.05
Analyst Rating and Forecast
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
IOL Chemicals and Pharmaceuticals Limited submitted its Structured Digital Database compliance certificate for Q4FY26 to stock exchanges, confirming full regulatory adherence with no non-compliance issues reported.
neutral
IOL Chemicals and Pharmaceuticals Limited announces special window from February 5, 2026 to February 4, 2027 for transfer and dematerialisation of physical securities under SEBI guidelines.
neutral
IOL Chemicals submitted newspaper publications for the re-launch of Second 100 Days Campaign 'Saksham Niveshak' in English, Punjabi, and Hindi newspapers on April 10, 2026.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,620.40
#1 3,88,788.24
36.80
#1 54,729.00
9.71
#1 10,980
16.07
33.27
6,361.50
1,68,877.84
68.31
9,712.00
18.67
2,191
-1.02
63.24
4,117.20
1,39,344.76
61.76
11,539.40
6.99
1,911
26.24
45.65
1,317.10
1,09,930.83
20.15
33,741.20
16.73
5,725
-15.28
61.94
2,296.10
1,04,941.69
22.91
22,909.50
13.74
3,306
#1 37.44
47.90
1,295.00
1,04,607.60
23.27
28,409.50
7.12
5,291
-57.18
60.61
2,267.40
93,599.42
52.47
12,744.20
#1 20.90
2,007
7.65
67.86
927.40
93,318.14
#1 18.96
23,511.00
18.55
4,615
-0.32
55.15
1,413.80
82,113.73
23.93
32,345.60
9.43
3,484
7.59
66.95
2,299.50
64,892.08
61.93
13,435.50
6.18
1,047
15.86
63.32
Growth Rate
Revenue Growth
-2.83 %
Net Income Growth
-24.78 %
Cash Flow Change
-38.36 %
ROE
-28.18 %
ROCE
-26.58 %
EBITDA Margin (Avg.)
-11.29 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
579
570
547
530
596
570
552
529
511
510
532
527
532
559
574
586
Expenses
527
509
510
481
492
491
481
476
454
451
484
476
465
490
511
534
EBITDA
52
61
37
49
104
80
71
53
57
59
48
51
67
70
64
51
Operating Profit %
8 %
10 %
6 %
8 %
16 %
13 %
12 %
9 %
10 %
10 %
8 %
9 %
12 %
11 %
10 %
8 %
Depreciation
11
11
11
12
12
14
16
16
16
17
18
19
19
20
20
20
Interest
2
3
4
5
5
4
4
4
3
2
4
5
4
4
4
4
Profit Before Tax
39
47
22
33
87
61
51
32
37
40
26
28
45
46
41
28
Tax
9
12
6
9
22
15
13
9
10
10
7
7
13
12
11
7
Net Profit
30
35
16
24
65
46
38
23
28
30
19
21
31
34
30
21
EPS in ₹
5.07
5.91
2.71
4.05
11.03
7.81
6.45
3.93
4.71
5.11
3.26
3.50
1.07
1.16
1.02
0.70

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
1,962
2,022
2,244
2,382
Fixed Assets
561
752
933
1,171
Current Assets
1,081
920
1,120
1,151
Capital Work in Progress
105
90
101
22
Investments
2
20
20
21
Other Assets
1,294
1,161
1,190
1,169
Total Equity & Liabilities
1,962
2,022
2,244
2,382
Current Liabilities
513
456
560
610
Non Current Liabilities
57
58
73
85
Total Equity
1,392
1,508
1,612
1,688
Reserve & Surplus
1,334
1,449
1,553
1,629
Share Capital
59
59
59
59

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
-29
-2
6
71
Investing Activities
-121
-120
-191
-154
Operating Activities
93
122
290
179
Financing Activities
-2
-4
-93
46

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
48.19 %
48.19 %
48.19 %
48.19 %
48.19 %
48.19 %
48.19 %
52.62 %
52.62 %
52.62 %
52.62 %
52.62 %
57.48 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.34 %
2.18 %
1.41 %
1.39 %
1.63 %
1.49 %
1.47 %
2.59 %
2.25 %
2.08 %
1.72 %
DIIs
0.04 %
0.04 %
0.36 %
0.50 %
0.02 %
0.02 %
0.06 %
0.17 %
0.02 %
0.26 %
0.36 %
0.37 %
0.30 %
0.10 %
0.08 %
0.08 %
0.07 %
0.02 %
0.04 %
0.03 %
0.02 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
27.30 %
28.03 %
29.86 %
30.15 %
30.29 %
31.15 %
31.15 %
30.92 %
30.49 %
29.28 %
30.28 %
30.63 %
30.98 %
31.48 %
31.31 %
31.23 %
31.43 %
30.22 %
29.97 %
30.51 %
31.03 %
Others
28.97 %
28.24 %
26.08 %
25.66 %
25.99 %
25.14 %
25.10 %
25.23 %
21.30 %
22.26 %
18.84 %
18.62 %
19.12 %
18.84 %
18.79 %
14.58 %
14.40 %
14.54 %
15.12 %
14.76 %
9.74 %
No of Share Holders
1,09,092
1,27,893
1,42,022
1,45,041
1,46,437
1,48,907
1,45,692
1,43,327
1,40,177
1,26,004
1,35,397
1,34,235
1,30,003
1,28,689
1,25,979
1,26,701
1,30,002
1,25,040
1,36,129
1,33,531
1,31,550

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 3 6 4 4 5 0.8 0.00
Dividend Yield (%) 0.00 0.00 0.00 2.72 8.48 7.07 5.53 8.18 1.1 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
12 Sept 2021 DIVIDEND Dividend
₹ 2.00 /share
08 Sept 2021 142.80 110.43
16 Feb 2022 DIVIDEND Dividend
₹ 4.00 /share
15 Feb 2022 91.71 77.42
17 Feb 2023 DIVIDEND Dividend
₹ 4.00 /share
17 Feb 2023 62.59 63.30
16 Feb 2024 DIVIDEND Dividend
₹ 5.00 /share
16 Feb 2024 87.56 82.25
23 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Aug 2024 74.72 93.30
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 79.07 74.06
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 72.62 73.57
18 Feb 2025 DIVIDEND Dividend
₹ 4.00 /share
18 Feb 2025 73.57 68.18
27 Dec 2024 SPLIT Split
2:10
11 Mar 2025 82.27 82.27
16 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
16 May 2025 65.00 77.10
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 94.23 95.10
22 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
22 Aug 2025 77.10 98.25
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 94.32 89.30
11 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2026 71.98 80.88
17 Feb 2026 DIVIDEND Dividend
₹ 1.00 /share
17 Feb 2026 80.88 74.81

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 13, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 10, 2026
Disclosure Under Regulation 30 - Participation In Saksham Niveshak CampaignApr 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 01, 2026
Closure of Trading WindowMar 26, 2026
Disclosure Under SEBI (Prohibition Of Insider Trading Regulation) 2015Mar 20, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 20, 2026
Disclosure Under SEBI (Prohibition Of Insider Trading Regulation) 2015Mar 19, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 19, 2026
Disclosure Under SEBI (Prohibition Of Insider Trading Regulation) 2015Mar 19, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 19, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 18, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 18, 2026
Disclosure Under SEBI (Prohibition Of Insider Trading Regulation) 2015Mar 18, 2026
Disclosure Under SEBI (Prohibition Of Insider Trading Regulation) 2015Mar 18, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 07, 2026
EDQM Issued CEP Certificate For METFORMIN HYDROCHLORIDE Process-IIMar 06, 2026
Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 02, 2026
EDQM Issued CEP Certificate For CLOPIDOGREL BESILATEFeb 24, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 18, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 18, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 12, 2026
Intimation On Communication To Members Regarding Tax Deducted At Source For Interim DividendFeb 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 12, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 11, 2026
Corporate Action-Board approves DividendFeb 11, 2026
Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2025Feb 11, 2026
Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2025Feb 11, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 04, 2026
Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 27, 2026
Board Meeting Intimation for Notice Of The Board MeetingJan 23, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2026
Closure of Trading WindowDec 29, 2025
EDQM Issued CEP Certificate For MINOXIDILDec 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 26, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 13, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 11, 2025
Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025Nov 11, 2025
Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025Nov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Board Meeting Intimation for Notice Of Board MeetingNov 04, 2025
EDQM Issued CEP Certificate For Sitagliptin Phosphate MonohydrateOct 27, 2025
Intimation Of Incorporation Of Wholly Owned SubsidiaryOct 24, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Oct 18, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.01%
43
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.07%
0
0.00%
0.01%

Technical Indicators

RSI(14)
Neutral
61.10
ATR(14)
Volatile
4.06
STOCH(9,6)
Neutral
77.84
STOCH RSI(14)
Neutral
60.48
MACD(12,26)
Bullish
0.87
ADX(14)
Strong Trend
25.08
UO(9)
Bearish
52.57
ROC(12)
Uptrend And Accelerating
13.37
WillR(14)
Neutral
-32.53